期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

甲状腺相关眼病的治疗现状及前景 被引量：3

原文传递
导出
摘要 甲状腺相关眼病（thyroid—associated ophthalmopathy，TAO），是一种器官特异性自身免疫性疾病。TAO年发病率男、女分别为16／10万和3／10万，80％～90％发生于Graves病，为Graves病最重要的甲状腺外表现。此外，少数桥本甲状腺炎、甲状腺功能减退和甲状腺功能正常者也可出现程度不同的眼病。
作者 杨刚毅 吴珮毓
机构地区 重庆医科大学附属第二医院内分泌科
出处 《中华内分泌外科杂志》 CAS 2011年第2期122-124,共3页 Chinese Journal of Endocrine Surgery
关键词 甲状腺相关眼病 特异性自身免疫性疾病 GRAVES病 甲状腺功能减退 治疗 甲状腺外表现 桥本甲状腺炎 年发病率
分类号 R581 [医药卫生—内分泌] R771.3 [医药卫生—眼科]
  • 相关文献

参考文献25

  • 1Garrity JA, Bahn RS. Pathogenesis of graves ophthahnopathy: im- plications for prediction, prevention and treatment [ J ]. Am J Ophthalmol, 2006, 142( 1 ) : 147-153.
  • 2Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives [ J ]. Endocr Rev, 2000, 21 (2) : 168-199.
  • 3Kim JM, LaBree L, Levin L, et al. The relation of Graves' oph- thalmopathy to circulating thyroid hormone status [ J ]. Br J Ophthalmol, 2004, 88 ( 1 ) :72-74.
  • 4Mourits MP, Koornneef L, Wiersinga WM, et al. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy : a novel approach[ J ]. Br J Ophthalmol, 1989, 73 (8) :639-644.
  • 5Pinchera A, Wiersinga W, Glinoer D, et al. Classification of eye changes of Graves' disease [ J]. Thyroid, 1992, 2 (3) :235-236.
  • 6Bartalena L, Baldesehi L, Dickinson A, et al. Consensus state- ment of the European Group on Graves' orbitopathy(EUGOGO) on managenment of GO[J]. Eur J Endocrinol, 2008, 158(3) :273- 285.
  • 7Le Moli R, Baldeschi L, Saeed P, et al. Determinants of liver damage associated with intravenous methylprednisolone pulse thera- py in Graves' ophthalmopathy [ J ]. Thyroid, 2007, 17 (4) : 357- 362.
  • 8Poonyathalang A, Preechawat P, Charoenkul W, et al. Retrobul- bar injection of triamcinolone in thyroid associated orbitopathy[ J ]. J Med Assoc Thai, 2005, 88(3) :345-349.
  • 9Chee E, Chee SP. Subconjunctival injection of triamcinolone in the treatment of lid retraction of patients with thyroid eye disease : a case series [ J ]. Eye ( Lond), 2008, 22 ( 2 ) :311-315.
  • 10Ebner R, Devoto MH, Weil D, et al. Trealment of thyroid associated ophthalmopathy with periocular injections of triamcinolone [J]. BrJ Ophthalmol, 2004, 88(11) :1380-1386.

二级参考文献6

共引文献9

同被引文献35

  • 1奚月芬,高芸.Graves眼病3种药物治疗方案的成本-效果分析[J].中国药房,2006,17(1):34-35. 被引量：1
  • 2王光琳,吕金凤,曹娟,等.甲状腺机能亢进突眼球后注射的治疗与护理体会[J].中华医学理论与实践杂志,2004,4(2):101-102.
  • 3Maheshwari R, Weis E. Thyroid associated orbitopathy[J]. lndian J Ophthalmol, 2012,60 ( 2 ) : 87.
  • 4Park JJ, Sullivan T J, Mortimer RH, et al. Assessing qual- ity of life in Australian patients with Graves' ophthalmop- athy[J]. Br J Ophthalmol, 2004,88 ( 1 ) : 75.
  • 5Farid M, Roch-Levecq AC, Levi L, et al. Psychological disturbance in graves ophthalmopathy[J]. Arch Ophthal- mol,2005,123(4) :491.
  • 6Terwee CB, Gerding MN, Dekker FW, et al. Develop- ment of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: The GO-QOL[J]. BrJ Ophthalmol, 1998,82(7) : 773.
  • 7Terwee CB, Gerding MN, Derkker FW, et al.Test-retest re- liability of the GO-QOL: a disease-specific quality of life questionnaire for patients with Graves' ophthalmopathy [J]. J Clin Epidemiol, 1999,52 (9) : 875.
  • 8Terwee CB, Dekker FW, Mourits MP, et al. Interpreta- tion and validity of changes in scores on the Graves' oph- thalmopathy quality of life questionnaire (GO-QOL)after different treatment [J]. Clin Endocrinol: Oxf, 2001, 54 (3):391.
  • 9Pointdujour R, Gutman J, Shinder R. Quality of life in a German graves orbitopathy population[J]. Am J Ophthal- mol, 2012,153(2) : 380.
  • 10Yeatts RP. Quality of life in patients with Graves' ophthal-mopathy[J]. Trans Am Ophthalmol Soc, 2005 ( 103 ) : 368.

引证文献3

二级引证文献6

中华内分泌外科杂志
2011年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部